Want to see IN:GUFICBIO full AI Analyst Report?

Gufic Biosciences Limited (GUFICBIO) Financial Statements

0 Followers

Gufic Biosciences Limited Financial Overview

Gufic Biosciences Limited's market cap is currently ₹41.94B. The company's EPS TTM is ₹7.32; its P/E ratio is 57.42; and it has a dividend yield of 0.02%. Gufic Biosciences Limited is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 9.44B	₹ 8.20B	₹ 8.07B	₹ 6.91B	₹ 7.79B
Gross Profit	₹ 3.40B	₹ 2.97B	₹ 4.07B	₹ 3.51B	₹ 3.56B
Operating Income	₹ 1.21B	₹ 1.14B	₹ 2.89B	₹ 2.52B	₹ 1.29B
EBITDA	₹ 1.54B	₹ 1.38B	₹ 1.48B	₹ 1.37B	₹ 1.48B
Net Income	₹ 642.15M	₹ 696.50M	₹ 861.36M	₹ 797.05M	₹ 958.40M
Balance Sheet
Cash & Short-Term Investments	₹ 762.17M	₹ 290.22M	₹ 11.37M	₹ 286.02M	₹ 116.08M
Total Assets	₹ 13.42B	₹ 11.69B	₹ 10.93B	₹ 8.61B	₹ 5.21B
Total Debt	₹ 4.05B	₹ 3.36B	₹ 3.33B	₹ 3.34B	₹ 643.87M
Net Debt	₹ 3.29B	₹ 3.07B	₹ 3.32B	₹ 3.06B	₹ 527.79M
Total Liabilities	₹ 6.77B	₹ 5.68B	₹ 5.60B	₹ 5.13B	₹ 2.52B
Stockholders' Equity	₹ 6.65B	₹ 6.01B	₹ 5.33B	₹ 3.48B	₹ 2.69B
Cash Flow
Free Cash Flow	₹ -180.11M	₹ 270.96M	₹ -1.20B	₹ -2.14B	₹ 187.86M
Operating Cash Flow	₹ 131.71M	₹ 1.03B	₹ -74.57M	₹ -265.87M	₹ 1.06B
Investing Cash Flow	₹ -319.73M	₹ -717.09M	₹ -1.02B	₹ -1.91B	₹ -945.89M
Financing Cash Flow	₹ 652.67M	₹ -163.26M	₹ 823.81M	₹ 2.34B	₹ -62.44M

Currency in INR

Gufic Biosciences Limited Earnings and Revenue History

Income Statement >

Gufic Biosciences Limited Debt to Assets

Balance Sheet >

Gufic Biosciences Limited Cash Flow

Cash Flow >

Gufic Biosciences Limited Forecast EPS vs Actual EPS

Earnings >